60
Views
14
CrossRef citations to date
0
Altmetric
Original Research

Methotrexate-coupled nanoparticles and magnetic nanochemothermia for the relapse-free treatment of T24 bladder tumors

, &
Pages 2793-2811 | Published online: 06 Apr 2017

References

  • Schenk-BraatEABangmaCHImmunotherapy for superficial bladder cancerCancer Immunol Immunother200554541442315565330
  • HinataNShirakawaTZhangZRadiation induces p53-dependent cell apoptosis in bladder cancer cells with wild-type-p53 but not in p53-mutated bladder cancer cellsUrol Res200331638739612955365
  • RampersaudENVujaskovicZInmanBAHyperthermia as a treatment for bladder cancerOncology (Williston Park)201024121149115521141697
  • IsselsRDHyperthermia adds to chemotherapyEur J Cancer200844172546255418789678
  • HildebrandtBWustPAhlersOThe cellular and molecular basis of hyperthermiaCrit Rev Oncol Hematol2002431335612098606
  • ZhengMYueCGongPSingle-step assembly of DOX/ICG loaded lipid A polymer nanoparticles for highly effective chemo-photothermalACS Nano2013732056206723413798
  • ZhaoPZhengMLuoZNIR-driven smart theranostic nanomedicine for on-demand drug release and synergistic antitumour therapySci Rep201551425826400780
  • HilgerIAndräWHergtRHiergeistRElectromagnetic heating of breast tumors in interventional radiology: in vitro and in vivo studies in human cadavers and mice20012182570
  • HilgerIHergtRKaiserWATowards breast cancer treatment by magnetic heatingJ Magn Magn Mater20052931314319
  • KossatzSLudwigRDähringHHigh therapeutic efficiency of magnetic hyperthermia in xenograft models achieved with moderate temperature dosages in the tumor areaPharm Res201431123274328824890197
  • LudwigRStapfMDutzSMüllerRTeichgräberUHilgerIStructural properties of magnetic nanoparticles determine their heating behavior – an estimation of the in vivo heating potentialNanoscale Res Lett20149160225404872
  • DeweyWCArrhenius relationships from the molecule and cell to the clinicInt J Hyperthermia200925132019219695
  • PurschkeMLaubachHJAndersonRRMansteinDThermal injury causes DNA damage and lethality in unheated surrounding cells: active thermal bystander effectJ Invest Dermatol20101301869219587691
  • FrankeKKetteringMLangeKKaiserWAHilgerIThe exposure of cancer cells to hyperthermia, iron oxide nanoparticles, and mitomycin C influences membrane multidrug resistance protein expression levelsInt J Nanomedicine2013835136323378758
  • HilgerIRappAGreulichKOKaiserWAAssessment of DNA damage in target tumor cells after thermoablation in miceRadiology2005237250050616244258
  • HilgerIHiergeistRHergtRWinnefeldKSchubertHKaiserWAThermal ablation of tumors using magnetic nanoparticles: an in vivo feasibility studyInvest Radiol2002371058058612352168
  • StapfMPömpnerNKetteringMHilgerIMagnetic thermoablation stimuli alter BCL2 and FGF-R1 but not HSP70 expression profiles in BT474 breast tumorsInt J Nanomedicine201510101931193925792827
  • ZakariaMBBelikAALiuCHPrussian blue derived nanoporous iron oxides as anticancer drug carriers for magnetic-guided chemotherapyChem Asian J20151071457146225944287
  • ChanESLCronsteinBNMechanisms of action of methotrexateBull NYU Hosp Joint Dis201371Suppl 158
  • StapfMPömpnerNTeichgräberUHilgerIHeterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermiaInt J Nanomedicine20161148550026893557
  • KetteringMRichterHWiekhorstFMinimal-invasive magnetic heating of tumors does not alter intratumoral nanoparticle accumulation, allowing for repeated therapy sessions: an in vivo study in miceNanotechnology2011225050510222107782
  • SpurlockCF3rdTossbergJTFuchsHAOlsenNJAuneTMMethotrexate increases expression of cell cycle checkpoint genes via JNK activationArthritis Rheum20126461780178922183962
  • GoncharovaSAFrankfurtOSEffect of methotrexate on the cell cycle of L1210 leukemiaCell Tissue Kinet197694333340945129
  • LimCUZhangYFoxMHCell cycle dependent apoptosis and cell cycle blocks induced by hyperthermia in HL-60 cellsInt J Hyperthermia2006221779116423754
  • CossRADeweyWCBamburgJREffects of hyperthermia on dividing Chinese hamster ovary cells and on microtubules in vitroCancer Res1982423105910717199378
  • BhuyanBKKinetics of cell kill by hyperthermiaCancer Res1979396 Pt 222772284376117
  • MindellJALysosomal acidification mechanismsAnn Rev Physiol2012741698622335796
  • TeranFJCasadoCMikuszeitNAccurate determination of the specific absorption rate in superparamagnetic nanoparticles under non-adiabatic conditionsAppl Phys Lett20121016062413
  • DutzSKetteringMHilgerIMüllerRZeisbergerMMagnetic multi-core nanoparticles for hyperthermia – influence of particle immobilization in tumour tissue on magnetic propertiesNanotechnology2011222626510221576784
  • GleichmarCUntersuchung des Einflusses der Umgebung auf die Eigenschaften magnetischer Nanoteilchen [Investigation of the influence of the environment on the properties of magnetic nanoparticles] [bachelor’s thesis]JenaUniversity of Applied Sciences Jena2009 German
  • OhtaMHandaAIwataHRufenachtDATsutsumiSPoly-vinyl alcohol hydrogel vascular models for in vitro aneurysm simulations: the key to low friction surfacesTechnol Health Care200412322523315328451
  • DähringHGrandkeJTeichgräberUHilgerIImproved hyperthermia treatment of tumors under consideration of magnetic nanoparticle distribution using micro-CT imagingMol Imaging Biol201517676376925896813
  • SaparetoSADeweyWCThermal dose determination in cancer therapyInt J Radiat Oncol Biol Phys19841067878006547421
  • GenestierLPaillotRQuemeneurLIzeradjeneKRevillardJPMechanisms of action of methotrexateImmunopharmacology2000472–324725710878292
  • JoannonPOviedoICampbellMTordecillaJHigh-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearancePediatr Blood Cancer2004431172215170885
  • MoghimiSMHunterACMurrayJCNanomedicine: current status and future prospectsFASEB J200519331133015746175
  • AlbaneseATangPSChanWCThe effect of nanoparticle size, shape, and surface chemistry on biological systemsAnnu Rev Biomed Eng20121411622524388
  • VioletMDelattreLTardivelMA major role for Tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditionsFront Cell Neurosci201488424672431
  • CooperMJHaluschakJJJohnsonDp53 mutations in bladder carcinoma cell linesOncol Res19946125695797787250
  • MarklIDJonesPAPresence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancerCancer Res19985823534853539850064
  • EsrigDElmajianDGroshenSAccumulation of nuclear p53 and tumor progression in bladder cancerN Engl J Med199433119125912647935683
  • KraljevicPSMarjanovicMPoznicMKraljMAdenovirally mediated p53 overexpression diversely influence the cell cycle of HEp-2 and CAL 27 cell lines upon cisplatin and methotrexate treatmentJ Cancer Res Clin Oncol2009135121747176119548002
  • BhondeMRHanskiMLBudcziesJDNA damage-induced expression of p53 suppresses mitotic checkpoint kinase hMps1: the lack of this suppression in p53MUT cells contributes to apoptosisJ Biol Chem2006281138675868516446370
  • XiongYHannonGJZhangHCassoDKobayashiRBeachDP21 Is a universal inhibitor of cyclin kinasesNature199336664567017048259214
  • DonnellanRChettyRCyclin E in human cancersFASEB J199913877378010224221
  • Martín-caballeroJFloresJMGarcía-palenciaPSerranoMTumor susceptibility of p21(Waf1/Cip1)-deficient miceCancer Res200161166234623811507077
  • HallMCLiYPongRCElyBSagalowskyAIHsiehJTThe growth inhibitory effect of p21 adenovirus on human bladder cancer cellsJ Urol200016331033103810688044
  • DongYChiSLBorowskyADFanYWeissRHCytosolic p21Waf1/Cip1 increases cell cycle transit in vascular smooth muscle cellsCell Signal200416226326914636896
  • YuanSSChangHLChenHWSelective cytotoxicity of squamo-cin on T24 bladder cancer cells at the S-phase via a Bax-, Bad-, and caspase-3-related pathwaysLife Sci200678886987416154156
  • KlopfleischRGruberADDifferential expression of cell cycle regulators p21, p27 and p53 in metastasizing canine mammary adeno-carcinomas versus normal mammary glandsRes Vet Sci2009871919619185891
  • PuttKSChenGWPearsonJMSmall-molecule activation of procaspase-3 to caspase-3 as a personalized anticancer strategyNat Chem Biol200621054355016936720
  • BoularesAHYakovlevAGIvanovaVRole of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis. Caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cellsJ Biol Chem199927433229322294010438458
  • OliverFJde la RubiaGRolliVRuiz-RuizMCde MurciaGMurciaJMImportance of Poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutantJ Biol Chem19982735033533335399837934
  • HuHJiangCLiGLüJPKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cellsCarcinogenesis20052681374138115845651
  • RichardDEBerraEGothiéERouxDPouysségurJp42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1J Biol Chem199927446326313263710551817
  • VantaggiatoCFormentiniIBondanzaABoniniCNaldiniLBrambillaRERK1 and ERK2 mitogen-activated protein kinases affect Ras-dependent cell signaling differentiallyJ Biol2006551416805921
  • PlattFMHurstCDTaylorCFGregoryWMHarndenPKnowlesMASpectrum of phosphatidylinositol 3-kinase pathway gene alterations in bladder cancerClin Cancer Res200915196008601719789314
  • FujioYNguyenTWenckerDKitsisRNWalshKAkt promotes survival of cardiomyocytes in vitro and protects against ischemia- reperfusion injury in mouse heartCirculation2000101666066710673259
  • FujioYGuoKManoTMitsuuchiYTestaJRWalshKCell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survivalMol Cell Biol19991975073508210373556
  • DudekHDattaSRFrankeTFRegulation of neuronal survival by the serine-threonine protein kinase AktScience199727553006616659005851
  • SomanathPRRazorenovaOVChenJByzovaTVAkt1 in endothelial cell and angiogenesisCell Cycle20065551251816552185
  • ShiojimaIWalshKRole of Akt signaling in vascular homeostasis and angiogenesisCirc Res200290121243125012089061
  • KitamuraTAsaiNEnomotoARegulation of VEGF-mediated angiogenesis by the Akt/PKB substrate GirdinNat Cell Biol200810332933718264090
  • VauxDLCorySAdamsJMBcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cellsNature198833561894404423262202
  • McDonnellTJDeaneNPlattFMbcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferationCell198957179882649247
  • ModugnoMBanfiPGasparriFMcl-1 antagonism Is a potential therapeutic strategy in a subset of solid cancersExp Cell Res2015332226727725486070
  • PalveVMallickSGhaisasGKannanSTeniTOverexpression of Mcl-1L splice variant is associated with poor prognosis and chemoresistance in oral cancersPLoS One2014911e11192725409302
  • TavariaMGabrieleTKolaIAndersonRLA hitchhiker’s guide to the human Hsp70 familyCell Stress Chaperones19961123289222585
  • MoranoKANew tricks for an old dog: the evolving world of Hsp70Ann N Y Acad Sci200711131114
  • García-CardeñaGFanRShahVDynamic activation of endothelial nitric oxide synthase by Hsp90Nature199839266788218249580552
  • SemenzaGLTargeting HIF-1 for cancer therapyNat Rev Cancer200331072173213130303
  • WangGLJiangBHRueEASemenzaGLHypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tensionProc Natl Acad Sci U S A19959212551055147539918
  • IyerNVKotchLEAganiFCellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alphaGenes Dev19981221491629436976
  • BosRvan der GroepPGreijerAELevels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinomaCancer20039761573158112627523
  • ZhongHDe MarzoAMLaughnerEOverexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastasesCancer Res199959225830583510582706
  • PalmerLASemenzaGLStolerMHJohnsRAHypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1Am J Physiol19982742 Pt 1L212L2199486205
  • WieczorekEJablonowskiZTomasikBMMP, VEGF and TIMP as prognostic factors in recurring bladder cancerClin Biochem201548181235124026197083
  • OlssonAKDimbergAKreugerJClaesson-WelshLVEGF receptor signalling – in control of vascular functionNat Rev Mol Cell Biol20067535937116633338
  • ClaussMMolecular biology of the VEGF and the VEGF receptor familySemin Thromb Hemost200026556156911129413
  • Claesson-WelshLSignal transduction by vascular endothelial growth factor receptorsBiochem Soc Transact200331Pt 12024
  • FongGHRossantJGertsensteinMBreitmanMLRole of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothe-liumNature1995376653566707596436
  • KerbelRSYuJTranJPossible mechanisms of acquired resistance to anti-angiogenic drugs: implications for the use of combination therapy approachesCancer Metastasis Rev2001201–2798611831651
  • MillerKDSweeneyCJSledgeGWCan tumor angiogenesis be inhibited without resistance?ClaussMBreierGMechanisms of Angiogenesis94 Experientia SupplementumBasel, SwitzerlandBirkhäuser-Verlag200595112
  • CasanovasOHicklinDJBergersGHanahanDDrug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumorsCancer Cell20058429930916226705
  • MookORFrederiksWMVan NoordenCJThe role of gelatinases in colorectal cancer progression and metastasisBiochim Biophys Acta200417052698915588763
  • BjörklundMKoivunenEGelatinase-mediated migration and invasion of cancer cellsBiochim Biophys Acta200517551376915907591
  • GiannelliGFalk-MarzillierJSchiraldiOStetler-StevensonWGQuarantaVInduction of cell migration by matrix metalloprotease-2 cleavage of laminin-5Science199727753232252289211848
  • VuTHShipleyJMBergersGMMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytesCell19989334114229590175
  • HeissigBHattoriKDiasSRecruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligandCell200210962563712062105
  • GialeliCTheocharisADKaramanosNKRoles of matrix metallo-proteinases in cancer progression and their pharmacological targetingFEBS J20112781162721087457
  • MinellaACLoebKRKnechtACyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivoGenes Dev200822121677168918559482
  • SoucekTPuschOHengstschläger-OttnadEAdamsPDHengstschlägerMDeregulated expression of E2F-1 induces cyclin A- and E-associated kinase activities independently from cell cycle positionOncogene19971419225122579178900
  • American Cancer Society ACBladder Cancer Available from: http://www.cancer.org/Cancer/BladderCancer/DetailedGuide/indexAccessed February 1, 2016